Why Duodenoscopes Are Hard to Clean: What the FDA Has Said
A duodenoscope is a flexible, lighted tube that a physician guides through the mouth, throat and stomach to the top of the small intestine. It is the instrument used for ERCP (endoscopic retrograde cholangiopancreatography), a procedure that diagnoses and treats problems in the bile ducts and pancreas. The FDA describes these devices as critical for diagnosing and treating serious, often life-threatening conditions, and in 2015 it put U.S. demand at roughly 500,000 ERCP procedures a year.
That is exactly why cleaning matters. This article explains what federal regulators have said publicly about why these scopes are difficult to clean, what they asked hospitals and manufacturers to do, and what has changed since. It is general information, not medical or legal advice.
Reusable scopes and the cleaning step between patients
Duodenoscopes are reusable. After each procedure, hospital staff run the scope through “reprocessing,” a multi-step routine of manual cleaning followed by high-level disinfection or sterilization. The FDA has described reprocessing as a detailed process that can allow infection to spread if the instructions are not followed at every step.
The elevator mechanism
At the tip of a duodenoscope sits a small moving part called the elevator, which angles instruments as they pass through the scope. In a February 2015 safety communication, the FDA said the elevator contains microscopic crevices that are hard to clean and can hold body fluids and debris even after cleaning and disinfection. Reports of infection had arisen even when facilities followed the manufacturer’s instructions.
The agency said it had received 75 adverse event reports, covering about 135 patients, between January 2013 and December 2014 involving possible transmission of microbes from reprocessed duodenoscopes. The infections reported included CRE (carbapenem-resistant Enterobacteriaceae), a group of bacteria that resist many antibiotics.
What the FDA recommended
In its 2015 communications, the FDA urged hospitals to:
- follow the manufacturer’s cleaning instructions closely;
- clean the elevator mechanism and the recesses around it by hand, even when an automated reprocessor is used;
- run a quality-control program for duodenoscope reprocessing;
- tell patients about the benefits and risks of ERCP; and
- consider pulling a scope from service if a patient infection might be linked to it.
In August 2015 the agency also listed supplemental measures facilities could add: culturing scopes to check for bacteria, sterilizing with ethylene oxide, using a liquid chemical sterilant system, or repeating high-level disinfection. The FDA said at the time that the benefits of these devices continue to outweigh the risks for appropriately selected patients, while acknowledging that the risk of infection cannot be eliminated entirely.
The studies that followed
In October 2015, the FDA ordered the three U.S. duodenoscope manufacturers, Olympus, Fujifilm and Pentax, to carry out postmarket studies of how the scopes are reprocessed in real-world settings.
In December 2018 the agency reported interim results showing higher-than-expected contamination after reprocessing. Up to 3% of properly collected samples tested positive for organisms the FDA classed as high concern. The agency said that following the manufacturer’s instructions, while critical, was not enough to prevent every infection. It also said an individual patient’s risk remains relatively low given how many of these devices are in use, and that infection-related reports had declined since 2015.
The same FDA statement noted a Department of Justice criminal action against Olympus over failing to adequately file adverse event reports about infections in Europe in 2012 and 2013 tied to its TJF-Q180V duodenoscope.
Design changes: disposable parts
The FDA’s duodenoscope page now describes a transition toward fully disposable duodenoscopes and models with disposable components. The agency has cleared a duodenoscope with a disposable elevator component, the very part it identified as hardest to clean.
What this means for patients
ERCP remains an important procedure, and many patients benefit from it. If you develop symptoms such as fever or chills after any endoscopic procedure, contact your health care provider promptly.
If you want to know more about the scope used in your care, you can ask the facility whether it uses duodenoscopes with disposable components and what quality-control measures it has for reprocessing. Patients and providers can also report problems with a device to the FDA’s MedWatch program at 1-800-332-1088.
Where the litigation fits in
Lawsuits against Olympus allege that its scopes were defectively designed and that the company failed to adequately warn about infection risks. Those are allegations, not findings by a court. You can read a summary of the regulatory history on our litigation timeline.
Sources
- FDA: Infections Associated with Reprocessed Duodenoscopes
- FDA statement on higher-than-expected contamination rates in duodenoscope studies (December 2018)
- Healio: FDA says design of ERCP endoscopes may hinder effective cleaning (February 19, 2015)
- MDedge: FDA guidance focuses on infections with reusable devices, including duodenoscopes
- Repertoire: Duodenoscopes still on FDA's radar (August 2015 supplemental measures)
- Healio: FDA warns of higher-than-expected contamination rates after duodenoscope reprocessing (January 17, 2019)
- MedTech Dive: FDA clears Pentax duodenoscope with disposable part
Facts in this article come from the sources listed above and were current when the article was published or last updated. Statements about lawsuits describe allegations, which are claims and not findings by a court.
This article is general information, not medical or legal advice. Reading it does not create an attorney-client relationship. If you have symptoms of an infection, contact your health care provider. Attorney advertising. Prior results do not guarantee a similar outcome.